ZHOU Hai-song, WANG Qing, YI Lang, et al. Effect of Yirui Capsule on Expression of Purinergic Receptors PX and AA in Livers of Hyperlipidemia Rats[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 142-145.
DOI:
ZHOU Hai-song, WANG Qing, YI Lang, et al. Effect of Yirui Capsule on Expression of Purinergic Receptors PX and AA in Livers of Hyperlipidemia Rats[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 142-145. DOI: 10.13422/j.cnki.syfjx.2015190142.
Effect of Yirui Capsule on Expression of Purinergic Receptors PX and AA in Livers of Hyperlipidemia Rats
Objective: To study the relationship between the inflammation and expression of hepatic purinergic receptors P2X7 and A2A in hyperlipidemia rats
and the intervention effect of Yirui capsule. Method: Fifty male rats were randomly divided into two groups. Ten rats were fed with normal diets as normal group
and forty rats were fed with high-fat diets as the observation group. After 14 d
the forty rats were further randomly divided into model group and Yirui capsule low
middle
high dose groups
10 rats for each group. Yirui capsules were administered ig to the treatment group for 30 days at 140
280
560 mg·kg-1 respectively. And then
the levels of lipids in serum were detected
tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) in serum were detected by enzyme-linked immunosorbant assay(ELISA)
and the expression of purinergic receptors P2X7 and A2A in livers were analyzed by RT-PCR. Result: The content of inflammatory cytokines TNF-α
IL-1β and the expression of purinergic receptors P2X7 and A2A in livers were increased in model group
compared with normal group (P<0.01). The content of inflammatory cytokines TNF-α
IL-1β and the expression of purinergic receptors P2X7 and A2A in livers were decreased in Yirui treatment group
compared with model group (P<0.01). Conclusion: Yirui capsule can regulate the expression of purinergic receptors in rat's liver
which is possibly relevant to the anti-inflammatory properties and amendment of lipid metabolism.
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis: A Randomized Controlled Trial
Mechanism of Wendantang in Intervention of ApoE-/- Hyperlipidemic Mice Based on Liver Metabolomics
Polygonati Odorati Rhizoma Polysaccharides Ameliorate Hyperlipidemia in Mice by Regulating Gut Microbiota
Wendantang Regulates Energy Metabolism in Treatment of Myocardial Ischemia via SIRT3/PGC-1α Pathway
Related Author
YANG Lele
LUO Danmei
CHEN Jiao
ZHANG Xiaobo
SONG Wei
ZHU Wenyu
ZHOU Xin
LI Xueping
Related Institution
Chengdu University of TCM
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Hospital of Chengdu University of TCM
Chengdu University of Traditional Chinese Medicine(TCM)
Research Center for Differentiation and Development of Traditional Chinese Medicine (TCM) Basic Theory/Jiangxi Province Key Laboratory of Biological Etiologies of TCM/First-Level Discipline Platform of Chinese and Western Integrative Medicine/Experimental Animal and Scientific Technology Center of Jiangxi University of Chinese Medicine/School of Pharmacy, Jiangxi University of Chinese Medicine